跳至主要内容
临床试验/TCTR20221215002
TCTR20221215002招募中2 期

Therapeutic efficiency and safety assessment of Centella asiatica capsule in patients with non-alcoholic steatohepatitis (NASH) in Thailand

(in process) the Royal College of Physicians of Thailand0 个研究点目标入组 54 人开始时间: 2022年12月15日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
54

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • 1). Age 18 years or more 2).Diagnosed with NASH based on clinical features and abdominal imaging

排除标准

  • 1). Not willing to participate to the study 2). Currently on other medications in treating NASH 3).Severe liver disease 4).Severe renal disease 5).Allergic to Centella asiatica 6).Pregnancy or lactation 7).Alcohol drinking (>21 standard drinks/week in males, or >14 standard drinks in females)

研究者

发起方
(in process) the Royal College of Physicians of Thailand

相似试验